WO1999054446A3 - Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind - Google Patents

Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind Download PDF

Info

Publication number
WO1999054446A3
WO1999054446A3 PCT/DE1999/001096 DE9901096W WO9954446A3 WO 1999054446 A3 WO1999054446 A3 WO 1999054446A3 DE 9901096 W DE9901096 W DE 9901096W WO 9954446 A3 WO9954446 A3 WO 9954446A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
overexpressed
acid sequences
human nucleic
normal pancreas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/001096
Other languages
English (en)
French (fr)
Other versions
WO1999054446A2 (de
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Original Assignee
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH filed Critical METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority to JP2000544778A priority Critical patent/JP2002512022A/ja
Priority to EP99945722A priority patent/EP1082420A2/de
Publication of WO1999054446A2 publication Critical patent/WO1999054446A2/de
Publication of WO1999054446A3 publication Critical patent/WO1999054446A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Es werden menschliche Nukleinsäuresequenzen - mRNA, cDNA, genomische Sequenzen - aus Pankreasnormalgewebe, die für Genprodukte oder Teile davon kodieren, und deren Verwendung beschrieben. Es werden weiterhin die über die Sequenzen erhältlichen Polypeptide und deren Verwendung beschrieben.
PCT/DE1999/001096 1998-04-19 1999-04-08 Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind Ceased WO1999054446A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000544778A JP2002512022A (ja) 1998-04-19 1999-04-08 正常な膵臓由来のヒト核酸配列
EP99945722A EP1082420A2 (de) 1998-04-19 1999-04-08 Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19818598.7 1998-04-19
DE19818598A DE19818598A1 (de) 1998-04-19 1998-04-19 Menschliche Nukleinsäuresequenzen aus Pankreasnormalgewebe

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09647801 A-371-Of-International 2000-12-20
US10/330,051 Division US20040002471A1 (en) 1998-04-19 2002-12-30 Human nucleic acid sequences which are overexpressed in normal pancreas tissue

Publications (2)

Publication Number Publication Date
WO1999054446A2 WO1999054446A2 (de) 1999-10-28
WO1999054446A3 true WO1999054446A3 (de) 2000-06-02

Family

ID=7865819

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001096 Ceased WO1999054446A2 (de) 1998-04-19 1999-04-08 Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind

Country Status (4)

Country Link
EP (1) EP1082420A2 (de)
JP (1) JP2002512022A (de)
DE (1) DE19818598A1 (de)
WO (1) WO1999054446A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020447A2 (en) * 1998-10-06 2000-04-13 Curagen Corporation Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
WO2000031243A1 (en) * 1998-11-20 2000-06-02 Fuso Pharmaceutical Industries, Ltd. Novel serine protease bssp5
CA2395872A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBL Database Entry T10937; Accession No. T10937 12.08.93 Bell, G.I and Takeda, J. Klon hbc153 *
HOHNE, M.W. ET AL.: "Frequent loss of expression of the potential tumor supressor gene DCC in ductal pancreatic adenocarcinoma", CANCER RESEARCH, vol. 52, no. 9, 1992, pages 2616 - 2619, XP002126739 *
TAKEDA, J. ET AL.: "A molecular inventory of human pancreatic islets: sequence analysis of 1000 cDNA clones", HUMAN MOLECULAR GENETICS, vol. 2, no. 11, 1993, pages 1793 - 1798, XP002059393 *

Also Published As

Publication number Publication date
WO1999054446A2 (de) 1999-10-28
EP1082420A2 (de) 2001-03-14
JP2002512022A (ja) 2002-04-23
DE19818598A1 (de) 1999-10-21

Similar Documents

Publication Publication Date Title
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
WO1999055858A3 (de) Menschliche nukleinsäuresequenzen aus pankreastumorgewebe
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
EP1308459A3 (de) Vollständige cDNA-Sequenzen
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
EP1440981A3 (de) Vollständige humane cDNS
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999053051A3 (en) 5' ests and encoded human proteins
WO1999006549B1 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
EP1033401A3 (de) Exprimierte Sequenzmarker und kodierte menschliche Proteine
WO1999054460A3 (de) Menschliche nukleinsäuresequenzen aus normalem blasengewebe
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
WO2001098491A3 (en) Osteolevin gene polymorphisms
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO1999047655A3 (de) Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist
WO1998011234A3 (en) Human protein kinases
EP1447413A3 (de) Vollständige humane cDNA
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO1999054446A3 (de) Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind
WO1998033937A3 (de) GENOMISCHE SEQUENZ DES HUMANEN ν-OPIOID-REZEPTOR GENES SOWIE SEINER VARIANTEN, POLYMORPHISMEN UND MUTATIONEN

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999945722

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09647801

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999945722

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999945722

Country of ref document: EP